Pharma OXIT ApS: Financial statements 2024
CVR: 37757292
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma OXIT ApS (CVR 37757292) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,478 and a net result of DKK -7,501 compared with DKK -9,689 the year before. Equity in the 2024 report amounted to DKK -112,426.
- Gross Profit
- DKK -7,478
- Profit/Loss
- DKK -7,501
- Equity
- DKK -112,426
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -7 t. | -8 t. | -112 t. | - |
| 2023 | - | -10 t. | -10 t. | -105 t. | - |
| 2022 | - | -16 t. | -16 t. | -95 t. | - |
| 2021 | - | -5 t. | -5 t. | -79 t. | - |
| 2020 | - | -5 t. | -5 t. | -74 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma OXIT ApS has published its annual report for 2023. Gross profit came to DKK -9,689, and the net result was DKK -9,689.
About Pharma OXIT ApS
Pharma OXIT ApS is a Danish company of the type Anpartsselskab based in Knebel, founded in 2016. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Tom Buris Nielsen. The company is owned by Tom Buris Nielsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,919 and a net result of DKK -7,939 compared with DKK -7,501 the year before. Equity in the 2025 report amounted to DKK -120,365.